Antihypertensive Tablet Franchise in Ahmedabad

Olmesartan Cilnidipine Chlorthalidone Tablet Supplier in Mumbai

Hypertension Tablet Distributor in Delhi

Cardiology Pharma Franchise in Bangalore

Blood Pressure Tablet Stockist in Hyderabad
Antihypertensive Tablet Manufacturer & Exporter in Chandigarh

Home/Products /olmesartan-medoxomil-20mg-cilnidipine-5mg-tablet

Olmeslide Trio 20 Tablet

Composition : Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹175/-

Olmeslide Trio 20 Tablet is a fixed-dose combination medication designed for the effective management of hypertension (high blood pressure). This formulation combines the therapeutic actions of three active ingredients:

  1. Olmesartan Medoxomil - An angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II, leading to a reduction in blood pressure and improved cardiovascular outcomes.
  2. Cilnidipine - A calcium channel blocker with a dual action on both L-type and N-type calcium channels, providing vasodilation and reducing peripheral resistance while minimizing side effects like reflex tachycardia.
  3. Chlorthalidone - A thiazide-like diuretic that reduces fluid retention by increasing the excretion of sodium and water, further aiding in blood pressure control.

The combination targets multiple pathways involved in hypertension, providing comprehensive blood pressure management and reducing the risk of complications like stroke, heart attack, and kidney damage. This tablet is particularly suitable for patients requiring multi-drug therapy for optimal blood pressure control.

Read More

About the Product

Olmeslide Trio 20 Tablet is a fixed-dose combination medication designed for the effective management of hypertension (high blood pressure). This formulation combines the therapeutic actions of three active ingredients:

  1. Olmesartan Medoxomil - An angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II, leading to a reduction in blood pressure and improved cardiovascular outcomes.
  2. Cilnidipine - A calcium channel blocker with a dual action on both L-type and N-type calcium channels, providing vasodilation and reducing peripheral resistance while minimizing side effects like reflex tachycardia.
  3. Chlorthalidone - A thiazide-like diuretic that reduces fluid retention by increasing the excretion of sodium and water, further aiding in blood pressure control.

The combination targets multiple pathways involved in hypertension, providing comprehensive blood pressure management and reducing the risk of complications like stroke, heart attack, and kidney damage. This tablet is particularly suitable for patients requiring multi-drug therapy for optimal blood pressure control.

Common side effects include dizziness, headache, fatigue, and mild swelling. Rarely, it may cause electrolyte imbalance or hypotension.

Indicated for the management of essential hypertension and reducing the risk of cardiovascular events.

Use only as directed by a healthcare professional. Regular monitoring of blood pressure and kidney function is recommended.

Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation